SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-24-004037
Filing Date
2024-11-25
Accepted
2024-11-25 11:02:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G 63763
  Complete submission text file 0000929638-24-004037.txt   65389
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 241492929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5TH FLOOR, BUILDING D 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD NANJING F4 210061
Business Address 5TH FLOOR, BUILDING D 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD NANJING F4 210061 267-356-9574
Biosion, Inc. (Filed by) CIK: 0002045933 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G